KSOS session: ENDOPHTHALMITIS 2026: TRANSLATING EVOLVING GLOBAL EVIDENCE TO CLINICAL PRACTICE
More than 3 decades after EVS results, endopthalmitis remain a devastating infection with significant visual morbidity despite advances in ophthalmic technology and care. The changing landscape of newer bugs, newer drugs, newer procedure and rapid diagnostic options has reemphasized the need to take stock of these advance for optimum patient care. This course aims to cover. 1. Evolving Epidemiology: 2. Rapid Diagnostics & Antibiotic Strategies: Intravitreal regimen resistance trends: 3. Management Shift: Beyond EVS- early MIVS vs tap and inject; 4. Prevention: Intra Cameral Ab / OT protocols, Injection safety bundles: 5. Medico legal Aspects: Preventive defends, documentation, counselling and consent :
Senior Vitreoretinal surgeon practising in Kerala for last 28 years.Has experience in managing complex vitreoretinal pathologies Has presented instruction courses on this topic at various national and international forum Edited and Published Book on " Posterior segment complications of cataract surgery'(Springer 2021) Senior Acheivement awardee of the american accademy of Ophthalmology